CD8A and hematologic disorder: To determine whether CXCR5+PD‐1+ CD8 T cells play a similar role in response to PD‐1 ICB in the human setting, we studied these cells in healthy individuals and in patients with hematologic malignancies with varying response rates to PD‐1 ICB.